Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (111-120 of 546) with videos related to

Pageof 55
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2011
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastomaHenriette Ingrid Melzer, Eva Coppenrath, Irene Schmid, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 24, 2017
Efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysisAmir Sabet, Alexander R Haug, Collin Eiden, et al.
Nuclear Medicine and Biology|August 23, 2020
Automated production of [<sup>18</sup>F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumorsSimon Lindner, Marcel Simmet, Franz Josef Gildehaus, et al.
EJNMMI Research|January 24, 2012
99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
MMW Fortschritte Der Medizin|March 8, 2017
[Prostate Cancer - Update 2017]Annika Herlemann, Alexander Kretschmer, Maria Apfelbeck, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 15, 2024
Quantitative assessment of cardiac <sup>123</sup>iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: Novel insight in disease monitoringJohannes M Hagen, Mathias J Zacherl, Matthias Brendel, et al.
Neuroimage|November 28, 2009
Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's diseaseYoshitaka Kumakura, Erik H Danielsen, Albert Gjedde, et al.
EJNMMI Physics|September 11, 2023
Estimation of relative biological effectiveness of <sup>225</sup>Ac compared to <sup>177</sup>Lu during [<sup>225</sup>Ac]Ac-PSMA and [<sup>177</sup>Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRASMikhail Rumiantcev, Wei Bo Li, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2022
<sup>68</sup>Ga-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancerLena M Unterrainer, Andrei Todica, Leonie Beyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2021
Are heterobivalent GRPR- and VPAC<sub>1</sub>R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?Simon Lindner, Henning Rudolf, Giovanna Palumbo, et al.
Pageof 55

Showing results (111-120 of 546) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2011
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastomaHenriette Ingrid Melzer, Eva Coppenrath, Irene Schmid, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 24, 2017
Efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysisAmir Sabet, Alexander R Haug, Collin Eiden, et al.
Nuclear Medicine and Biology|August 23, 2020
Automated production of [<sup>18</sup>F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumorsSimon Lindner, Marcel Simmet, Franz Josef Gildehaus, et al.
EJNMMI Research|January 24, 2012
99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
MMW Fortschritte Der Medizin|March 8, 2017
[Prostate Cancer - Update 2017]Annika Herlemann, Alexander Kretschmer, Maria Apfelbeck, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 15, 2024
Quantitative assessment of cardiac <sup>123</sup>iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: Novel insight in disease monitoringJohannes M Hagen, Mathias J Zacherl, Matthias Brendel, et al.
Neuroimage|November 28, 2009
Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's diseaseYoshitaka Kumakura, Erik H Danielsen, Albert Gjedde, et al.
EJNMMI Physics|September 11, 2023
Estimation of relative biological effectiveness of <sup>225</sup>Ac compared to <sup>177</sup>Lu during [<sup>225</sup>Ac]Ac-PSMA and [<sup>177</sup>Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRASMikhail Rumiantcev, Wei Bo Li, Simon Lindner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2022
<sup>68</sup>Ga-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancerLena M Unterrainer, Andrei Todica, Leonie Beyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2021
Are heterobivalent GRPR- and VPAC<sub>1</sub>R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?Simon Lindner, Henning Rudolf, Giovanna Palumbo, et al.
Pageof 55